Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Bone resorption predicts for skeletal complications in metastatic bone disease
2003
Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma
2000
Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience
2011
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases
2001
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Breast cancer
2016 Standout
Cancer to bone: a fatal attraction
2011 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
A Systematic Overview of Radiation Therapy Effects in Skeletal Metastases
2003
A Double-Blind, Placebo-Controlled, Randomized Trial of Oral Sodium Clodronate for Metastatic Prostate Cancer (MRC PR05 Trial)
2003
A Phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases
2003
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
2004 Standout
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma
2000
Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration
2005
Use of bisphosphonates in cancer patients
1996
Bisphosphonates and the prevention of metastasis
2000
Role of Bisphosphonates in Breast Cancer Therapy
2019
American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer
2000
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors
2005
Markers of bone resorption in patients treated with pamidronate
1998
Osteoporosis: now and the future
2011 Standout
Predictors of skeletal complications in patients with metastatic breast carcinoma
2000
The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells
1989 StandoutNature
Multiple Myeloma
2001
Risk of complications from bone metastases in breast cancer
2000
Comparison of the efficacy and safety of denosumab versus bisphosphonates in breast cancer and bone metastases treatment: A meta-analysis of randomized controlled trials
2014
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
2007
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
2012
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Bisphosphonates in breast cancer
2005
EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR ON NEUTROPENIA INDUCED BY CYTOTOXIC CHEMOTHERAPY
1988
Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function
2005
Bone health in cancer patients: ESMO Clinical Practice Guidelines
2014
Biochemical Markers of Bone Turnover in the Clinical Development of Drugs for Osteoporosis and Metastatic Bone Disease
2006
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
1998
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
Chronic arthritis leads to disturbances in the bone collagen network
2010 StandoutNobel
Multi-targeted therapy of cancer by genistein
2008 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Cancer treatment and survivorship statistics, 2012
2012 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
The evolving role of bisphosphonates
2001
The role of zoledronic acid in cancer: Clinical studies in the treatment and prevention of bone metastases
2001
NCCN Task Force Report: Bone Health in Cancer Care
2009
Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment
2005 Standout
Preclinical models of bone metastases
2001
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
Paradoxical roles of the immune system during cancer development
2006 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma
2003
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Mechanisms of Bone Metastasis
2004 Standout
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model
2002
Effects of Bone-Targeted Agents on Cancer Progression and Mortality
2012
Autologous Bone Marrow Transplantation
1989
Studies Comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for Assessment of Pain Intensity in Adults: A Systematic Literature Review
2011 Standout
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Cancer Pain Assessment in Clinical Trials. A Review of the Literature (1999–2002)
2005
Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates
2008
Bisphosphonates: Clinical Experience
2004
The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.
2001
The Effect of a Single Dose of Osteoprotegerin in Postmenopausal Women
2001
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
2010
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
2008
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients.
2003
Bone Marrow Transplant
1990 Standout
NCCN Task Force Report: Bone Health in Cancer Care
2013
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
2007 Standout
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
Adjuvant Clodronate Treatment Does Not Reduce the Frequency of Skeletal Metastases in Node-Positive Breast Cancer Patients: 5-Year Results of a Randomized Controlled Trial
2001
Randomized, Placebo-Controlled Trial of Clodronate in Patients With Primary Operable Breast Cancer
2002
Skeletal complications of malignancy
1997 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Guidelines for the management of thyroid cancer
2014 Standout
A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.
2006
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
A systematic review of the role of bisphosphonates in metastatic disease
2004
Works of Richard Leff being referenced
Sequential Treatment Including High-Dose Chemotherapy With Peripheral Blood Stem Cell Support in Patients With High-Risk Stage II-III Breast Cancer
1998
Phase I–II evaluation of rapid sequence tandem high-dose melphalan with peripheral blood stem cell support in patients with multiple myeloma
1998
Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial
1999
PP-8-8 Reduction of skeletal related complications in breast cancer patients with osteolytic bone metastases receiving hormone therapy, by monthly pamidronate sodium (AREDIA®) infusion
1996
Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastatic colon carcinoma.
1986